Endothelin receptor antagonist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Endothelin receptor antagonist, covering 2025-12-05 to 2025-12-05. Get the full timeline:
Most recent: Clinical Trial Update: SIRIUS - Initial Combination Therapy With an Endothelin Receptor Antagonist, a Phosphodiesterase-5 Inhibitor and Sotatercept in Patients With Newly Diagnosed Pulmonary Arterial Hypertension [Phase 2]